Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EXT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LAMTOR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FIBP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SGPL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNPH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HLA-DPA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EPS8L2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD40 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TUBGCP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARF5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C1orf106 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RNF114 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TUSC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD320 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LAPTM4B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SERPINA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
INO80B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNCB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF688 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on